The FDA approved the first 3D-printed drug in August; what other hot research projects are set to shape pharma’s 3D future?

Sitting Down With... David Baltimore, Nobel Laureate, President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology, USA.

Learning when to abandon an R&D project can open the door to potential future gains.

Often touted as ‘magic bullets’ against cancer, antibody-drug conjugates (ADCs) aim to combine the effectiveness of chemotherapy...

There are key benefits to having an industry standard for E&L studies – but a standard is only the beginning.

Knowledge managementof QbD can help bring benefits in medicine manufacture.

Redeploying or selling equipment without sufficient expertise can lead to liability risks.

More quality control testing is needed to ensure that antibiotics don't become targets for fraudsters.

CPhI Worldwide 2015 in Madrid is just around the corner. Are you ready for showtime?

DNA vaccine helps turn patients’ own cells into antibody-producing factories.